vs
IRONWOOD PHARMACEUTICALS INC（IRWD）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.5倍（$69.8M vs $47.7M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -4.8%，领先388.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -47.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -20.2%）
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
IRWD vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$47.7M
营收增速更快
RIGL
高出68.5%
-47.3%
净利率更高
RIGL
高出388.8%
-4.8%
两年增速更快
RIGL
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.7M | $69.8M |
| 净利润 | $-2.3M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 14.3% | 33.2% |
| 净利率 | -4.8% | 384.0% |
| 营收同比 | -47.3% | 21.2% |
| 净利润同比 | -200.9% | 1769.2% |
| 每股收益（稀释后） | $0.01 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRWDRIGL
| Q4 25 | $47.7M | $69.8M | ||
| Q3 25 | $122.1M | $69.5M | ||
| Q2 25 | $85.2M | $101.7M | ||
| Q1 25 | $41.1M | $53.3M | ||
| Q4 24 | $90.5M | $57.6M | ||
| Q3 24 | $91.6M | $55.3M | ||
| Q2 24 | $94.4M | $36.8M | ||
| Q1 24 | $74.9M | $29.5M |
净利润IRWDRIGL
| Q4 25 | $-2.3M | $268.1M | ||
| Q3 25 | $40.1M | $27.9M | ||
| Q2 25 | $23.6M | $59.6M | ||
| Q1 25 | $-37.4M | $11.4M | ||
| Q4 24 | $2.3M | $14.3M | ||
| Q3 24 | $3.6M | $12.4M | ||
| Q2 24 | $-860.0K | $-1.0M | ||
| Q1 24 | $-4.2M | $-8.2M |
毛利率IRWDRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率IRWDRIGL
| Q4 25 | 14.3% | 33.2% | ||
| Q3 25 | 61.8% | 40.9% | ||
| Q2 25 | 53.2% | 60.1% | ||
| Q1 25 | -70.7% | 23.9% | ||
| Q4 24 | 34.8% | 28.9% | ||
| Q3 24 | 28.0% | 25.4% | ||
| Q2 24 | 26.5% | 1.2% | ||
| Q1 24 | 14.7% | -23.6% |
净利率IRWDRIGL
| Q4 25 | -4.8% | 384.0% | ||
| Q3 25 | 32.8% | 40.2% | ||
| Q2 25 | 27.7% | 58.6% | ||
| Q1 25 | -90.9% | 21.5% | ||
| Q4 24 | 2.5% | 24.9% | ||
| Q3 24 | 4.0% | 22.5% | ||
| Q2 24 | -0.9% | -2.8% | ||
| Q1 24 | -5.6% | -27.9% |
每股收益（稀释后）IRWDRIGL
| Q4 25 | $0.01 | $14.11 | ||
| Q3 25 | $0.23 | $1.46 | ||
| Q2 25 | $0.14 | $3.28 | ||
| Q1 25 | $-0.23 | $0.63 | ||
| Q4 24 | $0.03 | $0.82 | ||
| Q3 24 | $0.02 | $0.70 | ||
| Q2 24 | $-0.01 | $-0.06 | ||
| Q1 24 | $-0.03 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-261.8M | $391.5M |
| 总资产 | $396.9M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资IRWDRIGL
| Q4 25 | $215.5M | $155.0M | ||
| Q3 25 | $140.4M | $137.1M | ||
| Q2 25 | $92.9M | $108.4M | ||
| Q1 25 | $108.5M | $77.1M | ||
| Q4 24 | $88.6M | $77.3M | ||
| Q3 24 | $88.2M | $61.1M | ||
| Q2 24 | $105.5M | $49.1M | ||
| Q1 24 | $121.5M | $49.5M |
总债务IRWDRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | $199.5M | $60.0M | ||
| Q2 25 | $199.3M | $60.0M | ||
| Q1 25 | $199.2M | $60.0M | ||
| Q4 24 | $199.0M | $60.0M | ||
| Q3 24 | $198.8M | $60.0M | ||
| Q2 24 | $198.6M | $60.0M | ||
| Q1 24 | $398.3M | $60.0M |
股东权益IRWDRIGL
| Q4 25 | $-261.8M | $391.5M | ||
| Q3 25 | $-264.2M | $117.6M | ||
| Q2 25 | $-308.2M | $81.9M | ||
| Q1 25 | $-334.1M | $18.6M | ||
| Q4 24 | $-301.3M | $3.3M | ||
| Q3 24 | $-311.3M | $-14.6M | ||
| Q2 24 | $-321.7M | $-29.9M | ||
| Q1 24 | $-330.5M | $-31.7M |
总资产IRWDRIGL
| Q4 25 | $396.9M | $513.6M | ||
| Q3 25 | $396.1M | $242.5M | ||
| Q2 25 | $342.9M | $206.7M | ||
| Q1 25 | $327.2M | $176.0M | ||
| Q4 24 | $350.9M | $164.0M | ||
| Q3 24 | $389.5M | $139.4M | ||
| Q2 24 | $395.6M | $128.4M | ||
| Q1 24 | $438.8M | $126.5M |
负债/权益比IRWDRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $74.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | — |
| 自由现金流率自由现金流/营收 | 156.3% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $127.0M | — |
8季度趋势，按日历期对齐
经营现金流IRWDRIGL
| Q4 25 | $74.6M | $22.0M | ||
| Q3 25 | $47.6M | $24.0M | ||
| Q2 25 | $-15.1M | $30.5M | ||
| Q1 25 | $20.0M | $-893.0K | ||
| Q4 24 | $15.2M | $14.5M | ||
| Q3 24 | $9.9M | $21.7M | ||
| Q2 24 | $33.5M | $302.0K | ||
| Q1 24 | $45.0M | $-5.0M |
自由现金流IRWDRIGL
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
自由现金流率IRWDRIGL
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
资本支出强度IRWDRIGL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率IRWDRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.19× | 0.86× | ||
| Q2 25 | -0.64× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 6.74× | 1.01× | ||
| Q3 24 | 2.71× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
